UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation

Annals of oncology, 2011-04, Vol.22 (4), p.939-946

2011

Volltextzugriff (PDF)

Autophagy and mTOR inhibition as mechanisms for combatting chemoresistance to standard chemotherapy: Final results of a phase I study of infusional cyclophosphamide (cy), pulse dexamethasone (dex), rapamycin (rapa) and hydroxychloroquine (HCQ)

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e283-e283

2015

Volltextzugriff (PDF)

Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas

Annals of oncology, 2022-09, Vol.33 (9), p.916-928

2022

Volltextzugriff (PDF)

Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism

Journal of Virus Eradication, 2017-12, Vol.3, p.19

2017

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1360-1365

2014

Volltextzugriff (PDF)

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

Bone marrow transplantation (Basingstoke), 2010-01, Vol.45 (1), p.39-47

2010

Volltextzugriff (PDF)

Effects of spleen status on early outcomes after hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.825-831

2013

Volltextzugriff (PDF)

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816

2012

Volltextzugriff (PDF)

Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage

Stem cell research, 2010, Vol.4 (1), p.57-68

2010

Volltextzugriff (PDF)

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.277-282

2016

Volltextzugriff (PDF)

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1479-1488

2010

Volltextzugriff (PDF)

Chronic GvHD-associated serositis and pericarditis

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1098-1104

2015

Volltextzugriff (PDF)

Rescue from failed growth factor and or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (12), p.909-917

2009

Volltextzugriff (PDF)

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization

Bone marrow transplantation (Basingstoke), 2012-12, Vol.47 (12), p.1526-1529

2012

Volltextzugriff (PDF)

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.777-781

2013

Volltextzugriff (PDF)

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.322-322

2016

Volltextzugriff (PDF)

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

Hematological oncology, 2019-06, Vol.37 (S2), p.307-307

2019

Volltextzugriff (PDF)

Long Term Engraftment Is Associated with Survival After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S257-S257

2012

Volltextzugriff (PDF)

Improved Outcome of Elderly Patients After Reduced Intensity Allogeneic Hematopoietic Cell Transplantation (HCT)

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S347-S348

2012

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation in Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: OHSU Experience

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S347-S347

2012

Volltextzugriff (PDF)

Multipotent Adult Progenitor Cells (Multistem®) Enhance Bone Marrow Recovery After Ablative Allogeneic Stem Cell Transplant

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S264-S264

2012

Volltextzugriff (PDF)

Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) in Chronic Lymphocytic Leukemia (CLL): Impact of Myeloablative (MA) Vs. Reduced-Intensity Conditioning (RIC) Regimens, and Impact of Total Body Irradiation (TBI)-Based MA Versus Chemotherapy (CT)-Based MA Conditioning

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S290-S291

2012

Volltextzugriff (PDF)

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

Transplant infectious disease, 2012-10, Vol.14 (5), p.468-478

2012

Volltextzugriff (PDF)

146: Impact of Health Insurance on Time to Approval and Time to Transplant Among Patients Receiving Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.55-56

2008

Volltextzugriff (PDF)

Prophylaxis of Acute GVHD Using Multistem® Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses in a Phase 1 Trial

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S264-S265

2012

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(21)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(14)
Oncology
(13)
Adult
(12)
Female
(12)
Immunology
(12)
Male
(12)
Middle Aged
(12)
Transplantation
(12)
Biophysics
(11)
Hematology
(11)
Stem Cell Transplantation
(11)
Aged
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(8)
Bone Marrow
(8)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation

Autophagy and mTOR inhibition as mechanisms for combatting chemoresistance to standard chemotherapy: Final results of a phase I study of infusional cyclophosphamide (cy), pulse dexamethasone (dex), rapamycin (rapa) and hydroxychloroquine (HCQ)

Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas

Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

Effects of spleen status on early outcomes after hematopoietic cell transplantation

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia

Chronic GvHD-associated serositis and pericarditis

Rescue from failed growth factor and or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY BASELINE TUMOR BURDEN IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

Long Term Engraftment Is Associated with Survival After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Improved Outcome of Elderly Patients After Reduced Intensity Allogeneic Hematopoietic Cell Transplantation (HCT)

Allogeneic Stem Cell Transplantation in Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: OHSU Experience

Multipotent Adult Progenitor Cells (Multistem®) Enhance Bone Marrow Recovery After Ablative Allogeneic Stem Cell Transplant

Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) in Chronic Lymphocytic Leukemia (CLL): Impact of Myeloablative (MA) Vs. Reduced-Intensity Conditioning (RIC) Regimens, and Impact of Total Body Irradiation (TBI)-Based MA Versus Chemotherapy (CT)-Based MA Conditioning

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

146: Impact of Health Insurance on Time to Approval and Time to Transplant Among Patients Receiving Hematopoietic Stem Cell Transplantation

Prophylaxis of Acute GVHD Using Multistem® Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses in a Phase 1 Trial

Suchergebnisse filtern